Ideally, he says that the future is in level three autonomy where they basically are their own little self-driven researchers, PIs that dont need as much human oversight or direction
Oral Wegovy (Oral Semaglutide): Offering the convenience of a daily pill, oral Wegovy is the first oral GLP-1 for weight management, achieving similar efficacy to its injectable counterpart with a 16.6% reduction in body weight
While some side effects have been seen (gastrointestinal disorders, hypotension, syncope, arthritic disorders, etc.), theyre at doses far exceeding what Ruhoy and Kaufman are using, and they have not seen these side effects in their patients
The most-cited study (Pyo et al
Collagen supplements for aging and wrinkles: a paradigm shift in the fields of dermatology and cosmetics
The average American takes GLP-1 medications for about six months before discontinuing